Onyx Bio, Inc. — Form D
Onyx Bio, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-22. The offering totals $5.5M, of which $5.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2022-03-22
- Form: D
- Accession: 0001915234-22-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.3M
- Remaining: $173K
- Investors: 15
- Date of first sale: 2022-01-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438454
Issuer
- Name: Onyx Bio, Inc.
- CIK: 0001915234
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 626 BANCROFT WAY SUITE A, BERKELEY, CA, 94710
- Phone: 415-617-5959
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Roger Chen | Director | Walnut, CA |
| Lance C Coleman | Director | Alameda, CA |
| Roger Chen | Executive Officer | Walnut, CA |
| Lance C Coleman | Executive Officer | Alameda, CA |
| Roger Chen | Promoter | Walnut, CA |
| Lance C Coleman | Promoter | Alameda, CA |
| Amit Lakhani | Director | Berkeley, CA |
Other filings by this issuer (1)
More